Global Drugs for Chronic Obstructive Pulmonary Disorder Market Research Report 2017

January 2017 | 127 pages | ID: GCC4C08475EEN
QYResearch

Abstracts

Notes:

Production, means the output of Drugs for Chronic Obstructive Pulmonary Disorder

Revenue, means the sales value of Drugs for Chronic Obstructive Pulmonary Disorder

This report studies Drugs for Chronic Obstructive Pulmonary Disorder in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

• AstraZeneca
• Boehringer Ingelheim
• GSK
• Novartis
• Teva Pharmaceuticals
• Ache Laboratorios Farmaceuticos
• Almirall
• Aquinox Pharmaceuticals
• Ario Pharma
• Asmacure
• Astellas Pharma
• BioMarck Pharmaceuticals
• Others

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Drugs for Chronic Obstructive Pulmonary Disorder in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Short-Acting Bronchodilators
• Corticosteroids
• Methylxanthines
• Long-Acting Bronchodilators
• Phosphodiesterase-4 Inhibitors

Split by application, this report focuses on consumption, market share and growth rate of Drugs for Chronic Obstructive Pulmonary Disorder in each application, can be divided into

• GOLD 1： FEV1 ≥ 80%
• GOLD 2： 50% ≤ FEV1 < 80%
• GOLD 3： 30% ≤ FEV1 < 50%
• GOLD 4： FEV1 < 30%

Contents

Global Drugs for Chronic Obstructive Pulmonary Disorder Market Research Report 2017

1 DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER MARKET OVERVIEW

1.1 Product Overview and Scope of Drugs for Chronic Obstructive Pulmonary Disorder
1.2 Drugs for Chronic Obstructive Pulmonary Disorder Segment by Type
  1.2.1 Global Production Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Type in 2015
  1.2.2 Short-Acting Bronchodilators
  1.2.3 Corticosteroids
  1.2.4 Methylxanthines
  1.2.5 Long-Acting Bronchodilators
  1.2.6 Phosphodiesterase-4 Inhibitors
1.3 Drugs for Chronic Obstructive Pulmonary Disorder Segment by Application
  1.3.1 Drugs for Chronic Obstructive Pulmonary Disorder Consumption Market Share by Application in 2015
  1.3.2 GOLD 1： FEV1 ≥ 80%
  1.3.3 GOLD 2： 50% ≤ FEV1 < 80%
  1.3.4 GOLD 3： 30% ≤ FEV1 < 50%
  1.3.5 GOLD 4： FEV1 < 30%
1.4 Drugs for Chronic Obstructive Pulmonary Disorder Market by Region
  1.4.1 North America Status and Prospect (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 China Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Drugs for Chronic Obstructive Pulmonary Disorder (2012-2022)

2 GLOBAL DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER MARKET COMPETITION BY MANUFACTURERS

2.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Production and Share by Manufacturers (2015 and 2016)
2.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Drugs for Chronic Obstructive Pulmonary Disorder Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Drugs for Chronic Obstructive Pulmonary Disorder Manufacturing Base Distribution, Sales Area and Product Type
2.5 Drugs for Chronic Obstructive Pulmonary Disorder Market Competitive Situation and Trends
  2.5.1 Drugs for Chronic Obstructive Pulmonary Disorder Market Concentration Rate
  2.5.2 Drugs for Chronic Obstructive Pulmonary Disorder Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Production and Market Share by Region (2012-2017)
3.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue (Value) and Market Share by Region (2012-2017)
3.3 Global Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
3.4 North America Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
3.6 China Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
3.7 Japan Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
3.9 India Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

4.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption by Regions (2012-2017)
4.2 North America Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Export, Import (2012-2017)
4.3 Europe Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Export, Import (2012-2017)
4.4 China Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Export, Import (2012-2017)
4.5 Japan Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Export, Import (2012-2017)
4.7 India Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Export, Import (2012-2017)

5 GLOBAL DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Production and Market Share by Type (2012-2017)
5.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Market Share by Type (2012-2017)
5.3 Global Drugs for Chronic Obstructive Pulmonary Disorder Price by Type (2012-2017)
5.4 Global Drugs for Chronic Obstructive Pulmonary Disorder Production Growth by Type (2012-2017)

6 GLOBAL DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER MARKET ANALYSIS BY APPLICATION

6.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption and Market Share by Application (2012-2017)
6.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER MANUFACTURERS PROFILES/ANALYSIS

7.1 AstraZeneca
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    7.1.2.1 Short-Acting Bronchodilators
    7.1.2.2 Corticosteroids
  7.1.3 AstraZeneca Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Boehringer Ingelheim
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    7.2.2.1 Short-Acting Bronchodilators
    7.2.2.2 Corticosteroids
  7.2.3 Boehringer Ingelheim Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 GSK
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    7.3.2.1 Short-Acting Bronchodilators
    7.3.2.2 Corticosteroids
  7.3.3 GSK Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Novartis
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    7.4.2.1 Short-Acting Bronchodilators
    7.4.2.2 Corticosteroids
  7.4.3 Novartis Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Teva Pharmaceuticals
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    7.5.2.1 Short-Acting Bronchodilators
    7.5.2.2 Corticosteroids
  7.5.3 Teva Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Ache Laboratorios Farmaceuticos
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    7.6.2.1 Short-Acting Bronchodilators
    7.6.2.2 Corticosteroids
  7.6.3 Ache Laboratorios Farmaceuticos Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Almirall
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    7.7.2.1 Short-Acting Bronchodilators
    7.7.2.2 Corticosteroids
  7.7.3 Almirall Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Aquinox Pharmaceuticals
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    7.8.2.1 Short-Acting Bronchodilators
    7.8.2.2 Corticosteroids
  7.8.3 Aquinox Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Ario Pharma
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    7.9.2.1 Short-Acting Bronchodilators
    7.9.2.2 Corticosteroids
  7.9.3 Ario Pharma Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Asmacure
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Drugs for Chronic Obstructive Pulmonary Disorder Product Type, Application and Specification
    7.10.2.1 Short-Acting Bronchodilators
    7.10.2.2 Corticosteroids
  7.10.3 Asmacure Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Astellas Pharma
7.12 BioMarck Pharmaceuticals
7.13 Others

8 DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER MANUFACTURING COST ANALYSIS

8.1 Drugs for Chronic Obstructive Pulmonary Disorder Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Drugs for Chronic Obstructive Pulmonary Disorder

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Drugs for Chronic Obstructive Pulmonary Disorder Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Drugs for Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISORDER MARKET FORECAST (2017-2022)

12.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue and Price Forecast (2017-2022)
  12.1.1 Global Drugs for Chronic Obstructive Pulmonary Disorder Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Drugs for Chronic Obstructive Pulmonary Disorder Price and Trend Forecast (2017-2022)
12.2 Global Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Import and Export Forecast by Regions (2017-2022)
  12.2.1 North America Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Chronic Obstructive Pulmonary Disorder
Figure Global Production Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Type in 2015
Figure Product Picture of Short-Acting Bronchodilators
Table Major Manufacturers of Short-Acting Bronchodilators
Figure Product Picture of Corticosteroids
Table Major Manufacturers of Corticosteroids
Figure Product Picture of Methylxanthines
Table Major Manufacturers of Methylxanthines
Figure Product Picture of Long-Acting Bronchodilators
Table Major Manufacturers of Long-Acting Bronchodilators
Figure Product Picture of Phosphodiesterase-4 Inhibitors
Table Major Manufacturers of Phosphodiesterase-4 Inhibitors
Table Drugs for Chronic Obstructive Pulmonary Disorder Consumption Market Share by Application in 2015
Figure GOLD 1： FEV1 ≥ 80% Examples
Figure GOLD 2： 50% ≤ FEV1 < 80% Examples
Figure GOLD 3： 30% ≤ FEV1 < 50% Examples
Figure GOLD 4： FEV1 < 30% Examples
Figure North America Drugs for Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Drugs for Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Drugs for Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Drugs for Chronic Obstructive Pulmonary Disorder Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Production of Key Manufacturers (2015 and 2016)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Production Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Chronic Obstructive Pulmonary Disorder Production Share by Manufacturers
Figure 2016 Drugs for Chronic Obstructive Pulmonary Disorder Production Share by Manufacturers
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers
Table 2016 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Manufacturers
Table Global Market Drugs for Chronic Obstructive Pulmonary Disorder Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Drugs for Chronic Obstructive Pulmonary Disorder Average Price of Key Manufacturers in 2015
Table Manufacturers Drugs for Chronic Obstructive Pulmonary Disorder Manufacturing Base Distribution and Sales Area
Table Manufacturers Drugs for Chronic Obstructive Pulmonary Disorder Product Type
Figure Drugs for Chronic Obstructive Pulmonary Disorder Market Share of Top 3 Manufacturers
Figure Drugs for Chronic Obstructive Pulmonary Disorder Market Share of Top 5 Manufacturers
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Production by Regions (2012-2017)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Production and Market Share by Regions (2012-2017)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Production Market Share by Regions (2012-2017)
Figure 2015 Global Drugs for Chronic Obstructive Pulmonary Disorder Production Market Share by Regions
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue by Regions (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Market Share by Regions (2012-2017)
Table 2015 Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Market Share by Regions
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
Table China Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
Table India Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption Market by Regions (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption Market Share by Regions (2012-2017)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption Market Share by Regions
Table North America Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Import & Export (2012-2017)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Import & Export (2012-2017)
Table China Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Import & Export (2012-2017)
Table Japan Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Import & Export (2012-2017)
Table India Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Import & Export (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Production by Type (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Production Share by Type (2012-2017)
Figure Production Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Type (2012-2017)
Figure 2015 Production Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Type
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue by Type (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Drugs for Chronic Obstructive Pulmonary Disorder by Type (2012-2017)
Figure 2015 Revenue Market Share of Drugs for Chronic Obstructive Pulmonary Disorder by Type
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Price by Type (2012-2017)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Production Growth by Type (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption by Application (2012-2017)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption Market Share by Application (2012-2017)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption Market Share by Application in 2015
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption Growth Rate by Application (2012-2017)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption Growth Rate by Application (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure AstraZeneca Drugs for Chronic Obstructive Pulmonary Disorder Market Share (2015 and 2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Boehringer Ingelheim Drugs for Chronic Obstructive Pulmonary Disorder Market Share (2015 and 2016)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure GSK Drugs for Chronic Obstructive Pulmonary Disorder Market Share (2015 and 2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Novartis Drugs for Chronic Obstructive Pulmonary Disorder Market Share (2015 and 2016)
Table Teva Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Teva Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Market Share (2015 and 2016)
Table Ache Laboratorios Farmaceuticos Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ache Laboratorios Farmaceuticos Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Ache Laboratorios Farmaceuticos Drugs for Chronic Obstructive Pulmonary Disorder Market Share (2015 and 2016)
Table Almirall Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Almirall Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Almirall Drugs for Chronic Obstructive Pulmonary Disorder Market Share (2015 and 2016)
Table Aquinox Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aquinox Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Aquinox Pharmaceuticals Drugs for Chronic Obstructive Pulmonary Disorder Market Share (2015 and 2016)
Table Ario Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ario Pharma Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Ario Pharma Drugs for Chronic Obstructive Pulmonary Disorder Market Share (2015 and 2016)
Table Asmacure Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Asmacure Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Asmacure Drugs for Chronic Obstructive Pulmonary Disorder Market Share (2015 and 2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Chronic Obstructive Pulmonary Disorder
Figure Manufacturing Process Analysis of Drugs for Chronic Obstructive Pulmonary Disorder
Figure Drugs for Chronic Obstructive Pulmonary Disorder Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Chronic Obstructive Pulmonary Disorder Major Manufacturers in 2015
Table Major Buyers of Drugs for Chronic Obstructive Pulmonary Disorder
Table Distributors/Traders List
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Production and Growth Rate Forecast (2017-2022)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue and Growth Rate Forecast (2017-2022)
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Price and Trend Forecast (2017-2022)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Production Forecast by Regions (2017-2022)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption Forecast by Regions (2017-2022)
Figure North America Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue and Growth Rate Forecast (2017-2022)
Table North America Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Export and Import Forecast (2017-2022)
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue and Growth Rate Forecast (2017-2022)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Export and Import Forecast (2017-2022)
Figure China Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue and Growth Rate Forecast (2017-2022)
Table China Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Export and Import Forecast (2017-2022)
Figure Japan Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue and Growth Rate Forecast (2017-2022)
Table Japan Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Export and Import Forecast (2017-2022)
Figure Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue and Growth Rate Forecast (2017-2022)
Table Southeast Asia Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Export and Import Forecast (2017-2022)
Figure India Drugs for Chronic Obstructive Pulmonary Disorder Production, Revenue and Growth Rate Forecast (2017-2022)
Table India Drugs for Chronic Obstructive Pulmonary Disorder Production, Consumption, Export and Import Forecast (2017-2022)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Production Forecast by Type (2017-2022)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Revenue Forecast by Type (2017-2022)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Price Forecast by Type (2017-2022)
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Consumption Forecast by Application (2017-2022)